Veraxa Biotech AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VRXA | HURA | MGNX | CTMX | PYXS | STRO | |
|---|---|---|---|---|---|---|
| Market cap | 134.34M | 109.61M | 147.15M | 512.06M | 198.30M | 164.82M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -2.8 | -1.6 | -5.0 | -1.5 | -1.6 |
| Price/book | -0.7 | 6.0 | 3.4 | 1.7 | 9.2 | -1.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −90.96% | −29.80% | +61.81% | −43.91% | −58.06% | −2.96% |
| Today | −4.04% | +3.93% | −0.86% | +7.80% | +1.22% | +4.52% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All VRXA news ›Verasonics Appoints New Senior Vice President, R&D
Medical Product Outsourcing offers a centralized destination where users can watch expert-led sessions anytime, anywhere Most recent C-Suite hire has nearly 30 years of medtech development experience. Verasonics Inc. has named Richard Van…
Vera Therapeutics Announces Chief Regulatory Officer Changes, Effective August 3, 2026
Vera Therapeutics, Inc. announced a planned transition of the Chief Regulatory Officer position. William Turner, current Chief Regulatory Officer of Vera Therapeutics, is planning to retire and... announced a planned transition of the…
With Safety Analysis Now Complete, Roswell Park Moves Forward With Expanded Study of CIMAvax
CIMAvax effectively starves cancer cells by stimulating an immune response against circulating EGF, which the cells need to grow and proliferate. The now-completed phase I clinical study led by Dr. Dy evaluated the safety of combining…
TenX Protocols Announces Appointment of Michael Frankel as Chief Financial Officer
"We are pleased to welcome Michael as Chief Financial Officer. His experience in corporate finance and financial leadership at high-growth technology companies brings valuable expertise to TenX. We also thank Martin for his contributions…
TenX Protocols appoints Michael Frankel as CFO
TenX Protocols (TNXIF) announced the appointment of Michael Frankel as Chief Financial Officer, effective October 23, 2026. He succeeds Martin Bui, who has stepped down from the role. TenX Protocols (TNXIF) announced the appointment of…
VERAXA Biotech AG And OmniAb, Inc. Advance Bispecific Antibody Drug Conjugate Program VXA-222 From Joint Discovery Collaboration
VERAXA Biotech AG announced the advancement of bispecific ADC program VXA-222, following successful achievement of a key technical milestone in its alliance with OmniAb, Inc. The program is moving... VERAXA Biotech AG announced the…
Veraxa Biotech Advances Bispecific Antibody Drug Conjugate Program
Veraxa Biotech is advancing the VXA-222 bispecific antibody drug conjugate program, a joint discovery collaboration with OmniAb , after achieving a key technical milestone, the company said... Biotechnology & Medical Research Veraxa…
VERAXA Biotech AG (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline
VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, is expanding its use of human-relevant testing methods across its oncology research programs, seeking to generate more clinically informative…
VERAXA Biotech’s Dual-Targeting Strategy Aims to Sharpen Cancer Therapy Precision
citybuzz - VERAXA Biotech (NASDAQ: VRXA) is developing antibody-based cancer therapies designed to improve treatment selectivity and potentially reduce toxicity to healthy tissues, according to a recent BioMedWire news
Femia to lead newly launched DOXA Re as President
19th October 2026 - Author: Kassandra Jimenez-Sanchez - DOXA, a US-based managing general underwriter (MGU) platform, has announced the formation of DOXA Re, a specialty property reinsurance MGU focused on quota share and related…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com6
- marketscreener.com4
- investors.veraxa.com3
- seekingalpha.com3
- tradingview.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 30 articles, not a forecast.